What are the recommended strategies for staging, phenotyping, and prognostication in cardiogenic shock?

Cardiogenic Shock: Staging, Phenotyping, and Prognostication

Cardiogenic shock requires early invasive hemodynamic assessment with pulmonary artery catheterization to guide phenotype-specific therapy, using the SCAI staging system (A-E) for risk stratification and specific hemodynamic parameters to identify distinct phenotypes that dictate treatment escalation.1

Staging Framework

The SCAI (Society for Cardiovascular Angiography and Interventions) staging system provides a five-stage continuum from "At Risk" (Stage A) to "Extremis" (Stage E), allowing identification of critical windows for preemptive stabilization particularly in Stage B before progression to refractory shock.2

Clinical Criteria for Diagnosis

• **Systolic blood pressure <90 mmHg for 30 minutes** or requirement for vasopressors/inotropes to maintain SBP >90 mmHg
• Evidence of end-organ hypoperfusion with lactate >2 mmol/L1

Hemodynamic Criteria for Severity Assessment

• Cardiac index (CI) <1.8 L/min/m² without support or <2.2 L/min/m² despite support
• Cardiac power output (CPO) <0.6 W indicates refractory shock11

Phenotyping Strategy

Invasive hemodynamics with pulmonary artery catheter (PAC) is essential to identify specific shock phenotypes that determine therapeutic approach.1 The phenotyping algorithm uses specific hemodynamic cutoffs:

Three Primary Phenotypes

1. Biventricular Cardiogenic Shock (Bi-V CS)

• CPO <0.6 W with PAPi >1.0
• RA >15 mmHg AND PCWP >15 mmHg
• Requires consideration of biventricular mechanical support1

2. Left Ventricular-Dominant CS (LV-dominant CS)

• CPO <0.6 W with PAPi <1.0
• RA <15 mmHg AND PCWP >15 mmHg
• May benefit from LV-specific mechanical support or vasodilators in normotensive hypoperfusion states11

3. Right Ventricular-Dominant CS (RV-dominant CS)

• CPO <0.6 W with PAPi <1.0
• RA >15 mmHg AND PCWP <15 mmHg
• Requires RV-specific support strategies; avoid devices that only provide RV support if progressive pulmonary hypertension is present1

Key Hemodynamic Parameters

• Pulmonary Artery Pulsatility Index (PAPi): Cutoff of 1.0 distinguishes RV involvement
• Right Atrial Pressure (RA): Cutoff of 15 mmHg identifies RV failure
• Pulmonary Capillary Wedge Pressure (PCWP): Cutoff of 15 mmHg identifies LV failure1

Emerging Machine Learning Phenotypes

Recent unsupervised machine learning analysis identified four distinct prognostic phenotypes based on age, ejection fraction, MAP, lactate, pH, creatinine, and ALT:3

1. "Compensated Low-Risk" (32.5% of patients): 22.4% mortality
2. "Metabolic Dysfunction" (27.6%): 41.9% mortality with severe LV dysfunction
3. "Multi-organ Failure" (13.5%): 78.4% mortality with severe metabolic, renal, hepatic derangement
4. "Elderly Decompensated" (26.4%): 60.7% mortality in older patients with moderate metabolic dysfunction

Prognostication Approach

Hemodynamic Signposts for Poor Prognosis

• CPO <0.6 W: Strongest predictor of refractory shock1
• CI <2.2 L/min/m²: Indicates inadequate cardiac output despite support1
• PAPi <1.0: Identifies high-risk RV phenotype2
• RA/PCWP ratio: Helps identify RV-dominant patterns2

Multimodal Risk Assessment

Beyond hemodynamics, integrate:4

• Lactate levels: Marker of tissue hypoperfusion and metabolic derangement
• Renal function (creatinine): Organ dysfunction indicator
• Hepatic function (ALT): Multi-organ involvement
• Inflammatory markers: Recognize CS as multisystem inflammatory disorder
• Echocardiography and VExUS score: Real-time assessment of forward flow and congestion2

Dynamic Monitoring Strategy

Prognostication must be longitudinal, not static.2 Monitor for:

• Clinical trajectory: Improvement vs. deterioration over 6-12 hours
• Response to therapy: Lactate clearance, urine output, mental status
• Hemodynamic trends: Serial CPO, CI, and filling pressure measurements

Critical Management Implications

Contraindications to Mechanical Circulatory Support

Identify these poor prognostic factors that preclude escalation:1

• Anoxic brain injury
• Irreversible end-organ failure
• Prohibitive vascular access
• Do Not Resuscitate status

Blood Pressure Targets by Phenotype

In cardiogenic shock, target MAP ≥65 mmHg as minimum threshold.5 Available data support this target, though higher targets may be reasonable in patients with chronic hypertension or high CVP values where organ perfusion pressure (MAP - CVP) becomes critical.5

Common Pitfalls

1. Delaying invasive hemodynamics: Clinical assessment alone cannot accurately phenotype CS—early PAC placement is essential1
2. Static assessment: Single hemodynamic measurements miss the dynamic nature of shock progression2
3. Ignoring RV phenotype: PAPi <1.0 with elevated RA identifies patients who may deteriorate with LV-only support1
4. Overlooking multi-organ dysfunction: Hepatic and renal markers provide critical prognostic information beyond cardiac parameters3

The standardized approach emphasizing early diagnosis, multidisciplinary care, selective MCS use, and invasive hemodynamics tailored to CS phenotype, supplemented by dedicated shock teams, represents the contemporary standard for improving outcomes.1